1. Home
  2. FDMT vs FACT Comparison

FDMT vs FACT Comparison

Compare FDMT & FACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FDMT
  • FACT
  • Stock Information
  • Founded
  • FDMT 2013
  • FACT 2024
  • Country
  • FDMT United States
  • FACT United States
  • Employees
  • FDMT N/A
  • FACT N/A
  • Industry
  • FDMT Biotechnology: Pharmaceutical Preparations
  • FACT
  • Sector
  • FDMT Health Care
  • FACT
  • Exchange
  • FDMT Nasdaq
  • FACT NYSE
  • Market Cap
  • FDMT 268.6M
  • FACT 250.5M
  • IPO Year
  • FDMT 2020
  • FACT 2024
  • Fundamental
  • Price
  • FDMT $4.28
  • FACT $9.99
  • Analyst Decision
  • FDMT Buy
  • FACT
  • Analyst Count
  • FDMT 10
  • FACT 0
  • Target Price
  • FDMT $35.00
  • FACT N/A
  • AVG Volume (30 Days)
  • FDMT 725.7K
  • FACT 714.0
  • Earning Date
  • FDMT 05-08-2025
  • FACT 01-01-0001
  • Dividend Yield
  • FDMT N/A
  • FACT N/A
  • EPS Growth
  • FDMT N/A
  • FACT N/A
  • EPS
  • FDMT N/A
  • FACT N/A
  • Revenue
  • FDMT $37,000.00
  • FACT N/A
  • Revenue This Year
  • FDMT $11,029.73
  • FACT N/A
  • Revenue Next Year
  • FDMT $44.15
  • FACT N/A
  • P/E Ratio
  • FDMT N/A
  • FACT N/A
  • Revenue Growth
  • FDMT N/A
  • FACT N/A
  • 52 Week Low
  • FDMT $3.73
  • FACT $9.85
  • 52 Week High
  • FDMT $36.25
  • FACT $10.05
  • Technical
  • Relative Strength Index (RSI)
  • FDMT 43.33
  • FACT N/A
  • Support Level
  • FDMT $3.73
  • FACT N/A
  • Resistance Level
  • FDMT $4.40
  • FACT N/A
  • Average True Range (ATR)
  • FDMT 0.35
  • FACT 0.00
  • MACD
  • FDMT 0.02
  • FACT 0.00
  • Stochastic Oscillator
  • FDMT 48.64
  • FACT 0.00

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

About FACT FACT II ACQUISITION CORP

FACT II Acquisition Corp is a blank check company.

Share on Social Networks: